|
[1]FREDERICK JS,SHIKHA SS,BENJAMIN LS.Familial hepatocellular cholestasis//Frederick JS,Ronald JS,William FB.Liver disease in children[M].4th ed,New York:Cambridge University Press,2014:199-215．
|
|
[2]WANG JS,LI LT.Advances in the study of familial intrahepatic cholestasis[J].Chin J Appl Clin Pediatr,2018,33(19):1451-1454．
|
|
[3]DAVIT-SPRAUL A,GONZALES E,BAUSSAN C,et al.Progressive familial intrahepatic cholestasis[J].Orphanet J Rare Dis,2009,4:1．
|
|
[4]GISSEN P,ARIAS IM.Structural and functional hepatocyte polarity and liver disease[J].J Hepatol,2015,63(4):1023-1037．
|
|
[5]YAN XM,HUANG ZH.Familial intranepatic cholestasis[J].J Clin Pediatr,2011,29(3):293-296．
|
|
[6]MOROTTI RA,SUCHY FJ,MAGID MS.Progressive familial intrahepatic cholestasis(PFIC)type 1,2,and 3:A review of the liver pathology findings[J].Semin Liver Dis,2011,31(1):3-10．
|
|
[7]SCHATZ SB,JNGST C,KEITEL-ANSELMO V,et al.Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset[J].Hepatol Commun,2018,2(5):504-514．
|
|
[8]BOGA S,JAIN D,SCHILSKY ML.Presentation of progressive familial intrahepatic cholestasis type 3 mimicking wilson disease:molecular genetic diagnosis and response to treatment[J].Pediatr Gastroenterol Hepatol Nutr,2015,18(3):202-208．
|
|
[9]KNISELY AS,STRANTNIEKS S,SCHEIMANN AO,et al.Bile salt export pump(BSEP)deficiency is a significant risk factor for both pediatric and adult hepatobiliary malignancy[J].Hepatology,2005,42(4):380A-381A．
|
|
[10]GUDBJARTSSON DF,HELGASON H,GUDJONSSON SA,et al.Large-scale whole-genome sequencing of the Icelandic population[J].Nat Genet,2015,47(5):435-444．
|
|
[11]MHATRE S,WANG Z,NAGRANI R,et al.Common genetic variation and risk of gallbladder cancer in India:A case-control genomewide association study[J].Lancet Oncol,2017,18(4):535-544．
|
|
[12]MIETHKE AG,ZHANG W,SIMMONS J,et al.Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice[J].Hepatology,2016,63(2):512-523．
|
|
[13]REICHERT MC,LAMMERT F.ABCB4 gene aberrations in human liver disease:An evolving spectrum[J].Semin Liver Dis,2018,38(4):299-307．
|
|
[14]SIEW SM,CUNNINGHAM SC,ZHU E,et al.Prevention of cholestatic liver diseaseand reduced tumorigenicity in a murine model of PF-IC Type 3 using hybrid AAV-piggy Bac gene therapy[J].Hepatology,2019,70(6):2047-2061．
|
|
[15]ARONSON SJ,BAKKER RS,SHI X,et al.Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice[J].J Hepatol,2019,71(1):153-162.
|
DownLoad: